[1]
2014. 99mTc-Labeled Bevacizumab via HYNIC for Imaging of Melanoma. Journal of Analytical Oncology. 3, 1 (Jan. 2014),  53–64. DOI:https://doi.org/10.6000/1927-7229.2014.03.01.9.